Blog
Marvell Technology Q1 Earnings Match Estimates, Revenues Rise Y/Y
Marvell Technology MRVL came out with first-quarter fiscal 2027 earnings of 80 cents per share, in line with the Zacks Consensus Estimate. The company reported earnings of 62 cents per share a year
Here's Why TT Stock Is a Compelling Pick for You Right Now
Trane Technologies plc TT, a designer, manufacturer, seller and servicer of climate control products for heating, ventilation and air conditioning ("HVAC") and transport solutions, has delivered an
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study
TG Therapeutics TGTX has announced positive top-line data from the late-stage ENHANCE study, which evaluated a consolidated single-infusion regimen of its sole marketed drug, Briumvi
UMC Rides on Portfolio Strength: Reason to Bet on the Stock Now?
United Microelectronics Corporation UMC is benefiting from strong momentum across several secular semiconductor trends, positioning it for sustained long-term growth. The foundry giant has
Synopsys Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
Synopsys SNPS reported non-GAAP earnings of $3.35 per share for the second quarter of fiscal 2026, which beat the Zacks Consensus Estimate by 5.7%. The bottom line decreased 8.7% on a year-over-year
POSCO and ReElement Launch Strategic U.S. Rare Earth Venture
POSCO Holdings, Inc.’s PKX subsidiary, POSCO International, has signed an agreement with ReElement Technologies Corporation to establish a joint venture for rare earth separation and purification
RF Industries vs. Amphenol: Which Connectivity Play Looks Stronger?
The connectivity infrastructure market is witnessing strong demand growth, fueled by expanding data center investments, rising network upgrades and increasing adoption of high-speed communication
Palo Alto Networks to Report Q3 Earnings: Buy, Sell or Hold the Stock?
Palo Alto Networks, Inc. PANW is scheduled to report its third-quarter fiscal 2026 results on June 2.
Palo Alto Networks projects its fiscal third-quarter revenues in the range of $2.941-$2.945
NTR Prices $1-Billion 5-Year and 10-Year Senior Notes Offering
Nutrien Ltd. NTR has priced two senior note offerings totaling $1 billion, aimed at managing debt maturities while maintaining liquidity and operational stability. The company is issuing $500
HPQ's Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
HP Inc. HPQ reported second-quarter fiscal 2026 earnings of 86 cents per share, which beat the Zacks Consensus Estimate by 19.4%. The company reported earnings of 71 cents per share a year ago
Solar ETF (TAN) Hits New 52-Week High
Invesco Solar ETF TAN is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 127.10% from its 52-week low price of $31.40 per share.
Are more
Analog Devices' Industrial Segment Picks Up Pace: What's Ahead?
Analog Devices’ ADI industrial segment continued its strong momentum in the second quarter of fiscal 2026, generating robust growth driven by automation, aerospace and defense, electronic test and
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
Shares of Corcept Therapeutics CORT were up 10.4% yesterday after the company announced that it will resubmit the new drug application (NDA) for its proprietary, selective cortisol modulator
Seanergy Maritime Holdings Corp (SHIP) Q1 Earnings and Revenues Beat Estimates
Seanergy Maritime Holdings Corp (SHIP) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to a loss of $0.27 per share a year
Credo Technology Before Q4 Earnings: Should Investors Buy the Stock?
Credo Technology Group Holding Ltd CRDO is scheduled to report fourth-quarter fiscal 2026 results on June 1, after the closing bell.
The Zacks Consensus Estimate for the bottom line for the
Energy ETFs Could Be Positioned for More Gains: Here's Why
Volatility in oil prices has remained a defining feature of global markets ever since the onset of the Middle East conflict. Against this backdrop, energy ETFs continue to stand out as a segment
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
Ironwood Pharmaceuticals IRWD announced that the FDA has approved the expanded use of its sole marketed drug, Linzess (linaclotide), for the treatment of functional constipation (FC) in pediatric
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
AbbVie ABBV announced the FDA approval of Decnupaz (pivekimab sunirine-pvzy) for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The disease is an
Petrobras Plans Major Gas Production Growth in the Amazon Region
Petrobras PBR, the Brazilian state-controlled integrated oil and gas company, has announced a bold plan to resume substantial investments in the Urucu natural gas hub, located in the Solimões Basin
Here's How IonQ's Expanding Commercial Traction Is Driving Its 2026 Outlook
In the first quarter, IonQ IONQ delivered robust revenue growth of 755% year over year, driven by strong demand for its industry-leading quantum computing systems and the growing commercial traction
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon’s ALC Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Growth momentum within the Surgical business is poised to boost the top
Earnings Preview: Lululemon (LULU) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Lululemon (LULU) reports results for the quarter ended April 2026. While this widely-known consensus outlook is





